US Agencies OK Resumption of J&J COVID Vaccine Use Despite Clot Risk
Voice of America
U.S. health officials on Friday ended an 11-day pause on COVID-19 vaccinations using Johnson & Johnson's one-dose shot, after scientific advisers decided its benefits outweighed the risk of rare blood clots.
The government found 15 vaccine recipients who had developed the clots, out of nearly 8 million people given the J&J shot. All were women, most under age 50. Three died; seven are still in hospitals. In the end, however, the Food and Drug Administration and Centers for Disease Control and Prevention decided that J&J's vaccine was a key to fighting the pandemic, and that the clot risk could be addressed with warnings to help younger women decide which shot to choose. The Advisory Committee on Immunization Practices' meeting on Friday followed an emergency meeting last week, the day after the announcement of the pause. At that time, members of the panel said they had too little time to make a recommendation.Director Lou Ye is pictured during a photo call for the film "An Unfinished Film," presented as part of Special Screenings at the 77th Cannes Film Festival in Cannes, France, May 17, 2024. From left, producer Philippe Bober, producer Yingli Ma, director Lou Ye, actor Hao Qin and actor Huang Xuan are pictured during a photo call for "An Unfinished Film" at the Cannes Film Festival in France, May 17, 2024. FILE - Chinese artist Ai Weiwei takes pictures in front of his pieces displayed during the press preview for the exhibition "Ai Weiwei: Making Sense" at the Design Museum in London, April 4, 2023. FILE - In this May 30, 2019, photo, a computer screen shows web content from outside China, including a clip of Chinese singer Li Zhi singing his song "The Square."